USANA HEALTH SCIENCES INC (USNA)
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Sector: Medicinal Chemicals & Botanical Products
Industry: Packaged Foods
USANA Health Sciences, Inc.
Trials need funding. See this company's dilution risk and cash position.
- Not applicableCompleted
Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health
MVM/phytochemical supplement, Placebo
Healthy
NCT03146312Enrollment24StartApr 2017Primary CompletionJun 2017CompletionJun 2017 - Not applicableCompleted
Effect of a MVM Dietary Supplement on Indices of Human Health
MVM/phytochemical supplement, Placebo
Metabolic Syndrome
NCT03488992Enrollment65StartJan 2017Primary CompletionFeb 2018CompletionFeb 2018 - Not applicableCompleted
A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition
beta glucan
Protective Qi Insufficiency (a Condition Term From TCM)
NCT03782974Enrollment207StartJan 2019Primary CompletionJun 2019CompletionJun 2019 - Not applicableCompleted
An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency
Proglucamune
Protective Qi Insufficiency
NCT03829228Enrollment30StartMar 2018Primary CompletionJun 2018CompletionJun 2018 - Not applicableCompleted
The Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste
Oral probiotic, Placebo
Oral Health
NCT05330793Enrollment105StartOct 2021Primary CompletionDec 2022CompletionDec 2022 - Not applicableUnknown status
A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers
Treatment, Placebo
Upper Respiratory Tract Infections, Mental Stress
NCT05917015Enrollment45StartMar 2023Primary CompletionDec 2023est.CompletionDec 2023est. - Not applicableCompleted
The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.
Treatment (CopaPrime+ (USANA Health Sciences), Placebo
Reaction Time
NCT05926050Enrollment41StartSep 2021Primary CompletionAug 2022CompletionAug 2022 - Not applicableUnknown status
Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.
Treatment 1, Treatment 2
Safety Issues, Tolerance
NCT06442293Enrollment18StartJul 2024est.Primary CompletionAug 2024est.CompletionAug 2024est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Not applicable | Completed | MVM/phytochemical supplement, Placebo | NCT03146312 |
| Not applicable | Completed | MVM/phytochemical supplement, Placebo | NCT03488992 |
| Not applicable | Completed | beta glucan | NCT03782974 |
| Not applicable | Completed | Proglucamune | NCT03829228 |
| Not applicable | Completed | Oral probiotic, Placebo | NCT05330793 |
| Not applicable | Unknown status | Treatment, Placebo | NCT05917015 |
| Not applicable | Completed | Treatment (CopaPrime+ (USANA Health Sciences), Placebo | NCT05926050 |
| Not applicable | Unknown status | Treatment 1, Treatment 2 | NCT06442293 |